1 Dolgin E. How COVID unlocked the power of RNA vaccines. Nature. 2021;589(7841):189–91.
2 Scheel B, Aulwurm S, Probst J, Stitz L, Hoerr I, Rammensee HG, et al. Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA. Eur J Immunol. 2006;36(10):2807–16.
3 Pascolo S. Sortir de la pandémie de COVID-19 grâce au vaccin à ARNm. Forum Med Suisse. 2021;21(7–8):114–20.
4 Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520(7549):692–6.
5 Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618–30.
6 Stitz L. mRNA-basierte Immunprophylaxe gegen Influenzavirusinfektionen. Forum Med Suisse. 2013;13(24):487–89.
7 Servick K. mRNA’s next challenge: Will it work as a drug? Science. 2020;370(6523):1388–9.
8 Krienke C, Kolb L, Diken E, Streuber M, Kirchhoff S, Bukur T, et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science. 2021;371(6525):145–53.